These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
224 related articles for article (PubMed ID: 30002222)
1. The Human FSGS-Causing Hall G; Lane BM; Khan K; Pediaditakis I; Xiao J; Wu G; Wang L; Kovalik ME; Chryst-Stangl M; Davis EE; Spurney RF; Gbadegesin RA J Am Soc Nephrol; 2018 Aug; 29(8):2110-2122. PubMed ID: 30002222 [TBL] [Abstract][Full Text] [Related]
2. Mutations in the gene that encodes the F-actin binding protein anillin cause FSGS. Gbadegesin RA; Hall G; Adeyemo A; Hanke N; Tossidou I; Burchette J; Wu G; Homstad A; Sparks MA; Gomez J; Jiang R; Alonso A; Lavin P; Conlon P; Korstanje R; Stander MC; Shamsan G; Barua M; Spurney R; Singhal PC; Kopp JB; Haller H; Howell D; Pollak MR; Shaw AS; Schiffer M; Winn MP J Am Soc Nephrol; 2014 Sep; 25(9):1991-2002. PubMed ID: 24676636 [TBL] [Abstract][Full Text] [Related]
3. Effects of a novel ANLN E841K mutation associated with SRNS on podocytes and its mechanism. Lin L; Ye Y; Fu H; Gu W; Zhao M; Sun J; Cao Z; Huang G; Xie Y; Liu F; Li L; Li Q; Mao J; Hu L Cell Commun Signal; 2023 Nov; 21(1):324. PubMed ID: 37957688 [TBL] [Abstract][Full Text] [Related]
4. Rac1 in podocytes promotes glomerular repair and limits the formation of sclerosis. Asao R; Seki T; Takagi M; Yamada H; Kodama F; Hosoe-Nagai Y; Tanaka E; Trejo JAO; Yamamoto-Nonaka K; Sasaki Y; Hidaka T; Ueno T; Yanagita M; Suzuki Y; Tomino Y; Asanuma K Sci Rep; 2018 Mar; 8(1):5061. PubMed ID: 29567961 [TBL] [Abstract][Full Text] [Related]
5. Notoginsenoside R1 attenuates glucose-induced podocyte injury via the inhibition of apoptosis and the activation of autophagy through the PI3K/Akt/mTOR signaling pathway. Huang G; Zou B; Lv J; Li T; Huai G; Xiang S; Lu S; Luo H; Zhang Y; Jin Y; Wang Y Int J Mol Med; 2017 Mar; 39(3):559-568. PubMed ID: 28112381 [TBL] [Abstract][Full Text] [Related]
6. Cucurbitacin E inhibits esophageal carcinoma cell proliferation, migration, and invasion by suppressing Rac1 expression through PI3K/AKT/mTOR pathway. Zhang L; Liang H; Xin Y Anticancer Drugs; 2020 Sep; 31(8):847-855. PubMed ID: 32568828 [TBL] [Abstract][Full Text] [Related]
7. Arhgap24 inactivates Rac1 in mouse podocytes, and a mutant form is associated with familial focal segmental glomerulosclerosis. Akilesh S; Suleiman H; Yu H; Stander MC; Lavin P; Gbadegesin R; Antignac C; Pollak M; Kopp JB; Winn MP; Shaw AS J Clin Invest; 2011 Oct; 121(10):4127-37. PubMed ID: 21911940 [TBL] [Abstract][Full Text] [Related]
8. [Down-regulation of PHLPP1 expression ameliorates high glucose-induced autophagy inhibition and apoptosis promotion of podocytes by activating PI3K/AKT/mTOR pathway]. Cai G; Zhang J; Wang R Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2021 Jan; 37(1):8-15. PubMed ID: 33441223 [TBL] [Abstract][Full Text] [Related]
9. TbetaRI independently activates Smad- and CD2AP-dependent pathways in podocytes. Xavier S; Niranjan T; Krick S; Zhang T; Ju W; Shaw AS; Schiffer M; Böttinger EP J Am Soc Nephrol; 2009 Oct; 20(10):2127-37. PubMed ID: 19679673 [TBL] [Abstract][Full Text] [Related]
10. ANLN promotes carcinogenesis in oral cancer by regulating the PI3K/mTOR signaling pathway. Wang B; Zhang XL; Li CX; Liu NN; Hu M; Gong ZC Head Face Med; 2021 Jun; 17(1):18. PubMed ID: 34082790 [TBL] [Abstract][Full Text] [Related]
11. The Calcium-Dependent Protease Calpain-1 Links TRPC6 Activity to Podocyte Injury. Verheijden KAT; Sonneveld R; Bakker-van Bebber M; Wetzels JFM; van der Vlag J; Nijenhuis T J Am Soc Nephrol; 2018 Aug; 29(8):2099-2109. PubMed ID: 29954830 [TBL] [Abstract][Full Text] [Related]
12. CD2-associated protein participates in podocyte apoptosis via PI3K/Akt signaling pathway. Ren Q; You Yu S J Recept Signal Transduct Res; 2016; 36(3):288-91. PubMed ID: 26584949 [TBL] [Abstract][Full Text] [Related]
13. A comprehensive immunohistochemical and molecular approach to the PI3K/AKT/mTOR (phosphoinositide 3-kinase/v-akt murine thymoma viral oncogene/mammalian target of rapamycin) pathway in bladder urothelial carcinoma. Korkolopoulou P; Levidou G; Trigka EA; Prekete N; Karlou M; Thymara I; Sakellariou S; Fragkou P; Isaiadis D; Pavlopoulos P; Patsouris E; Saetta AA BJU Int; 2012 Dec; 110(11 Pt C):E1237-48. PubMed ID: 23107319 [TBL] [Abstract][Full Text] [Related]